HUTCHMED (China) Ltd Files 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Dec 30, 2025 · CIK: 1648257
Sentiment: neutral
Topics: disclosure, foreign-issuer, regulatory-filing
TL;DR
HUTCHMED (China) Ltd filed a 6-K on 12/30/25, confirming 20-F filings and Hong Kong HQ.
AI Summary
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 30, 2025. This report is for the month of December 2025 and indicates the company files annual reports under Form 20-F. The company is based in Hong Kong and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides routine disclosure for HUTCHMED (China) Limited, a foreign private issuer, informing the SEC and investors about its reporting status and location.
Risk Assessment
Risk Level: low — This is a routine administrative filing (6-K) that does not contain new financial or operational information.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- Hutchison China MediTech Ltd (company) — Former company name
- 20251230 (date) — Filing date and period of report
- 001-37710 (other) — SEC file number
- Hong Kong (location) — Principal executive offices location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer may be required to disclose or make public in its home country.
What is HUTCHMED (China) Limited's filing status regarding annual reports?
HUTCHMED (China) Limited indicates it files annual reports under cover of Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on December 30, 2025.
Where are HUTCHMED (China) Limited's principal executive offices located?
The principal executive offices of HUTCHMED (China) Limited are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
What was HUTCHMED (China) Limited's former name?
HUTCHMED (China) Limited's former name was Hutchison China MediTech Ltd, with a date of name change on July 16, 2015.
Filing Stats: 185 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2025-12-30 06:02:14
Filing Documents
- hcm-20251230x6k.htm (6-K) — 23KB
- hcm-20251230xex99d1.htm (EX-99.1) — 23KB
- hcm-20251230xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-25-000089.txt ( ) — 52KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2025 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to NDA a cceptance in China with p riority r eview s tatus for s avolitinib for the treatment of g astric c ancer p atients with MET a mplification 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: December 30, 2025 3